129 related articles for article (PubMed ID: 33556883)
1. MicroRNAs differential expression profile in metastatic colorectal cancer: A pilot study with literature review.
Francone E; Gentilli S; Santori G; Stabilini C; Fornaro R; Frascio M
Surg Oncol; 2021 Jun; 37():101524. PubMed ID: 33556883
[TBL] [Abstract][Full Text] [Related]
2. Combined miRNA profiling and proteomics demonstrates that different miRNAs target a common set of proteins to promote colorectal cancer metastasis.
Torres S; Garcia-Palmero I; Bartolomé RA; Fernandez-Aceñero MJ; Molina E; Calviño E; Segura MF; Casal JI
J Pathol; 2017 May; 242(1):39-51. PubMed ID: 28054337
[TBL] [Abstract][Full Text] [Related]
3. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer.
Tang Y; Zhao Y; Song X; Song X; Niu L; Xie L
J Clin Lab Anal; 2019 Nov; 33(9):e23004. PubMed ID: 31420913
[TBL] [Abstract][Full Text] [Related]
5. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease.
Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883
[TBL] [Abstract][Full Text] [Related]
6. Identification of high-risk Dukes B colorectal cancer by microRNA expression profiling: a preliminary study.
Aslam MI; Venkatesh J; Jameson JS; West K; Pringle JH; Singh B
Colorectal Dis; 2015 Jul; 17(7):578-88. PubMed ID: 25557290
[TBL] [Abstract][Full Text] [Related]
7. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
8. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.
Wang LG; Gu J
Cancer Epidemiol; 2012 Feb; 36(1):e61-7. PubMed ID: 22018950
[TBL] [Abstract][Full Text] [Related]
9. MiR-486-5p Downregulation Marks an Early Event in Colorectal Carcinogenesis.
Kelley KA; Wieghard N; Chin Y; Potter A; Mori M; Wong MH; Chin K; Tsikitis VL
Dis Colon Rectum; 2018 Nov; 61(11):1290-1296. PubMed ID: 30239392
[TBL] [Abstract][Full Text] [Related]
10. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
11. Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer.
Li W; Chang J; Tong D; Peng J; Huang D; Guo W; Zhang W; Li J
Oncotarget; 2017 May; 8(22):35783-35791. PubMed ID: 28415758
[TBL] [Abstract][Full Text] [Related]
12. Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease.
Vickers MM; Bar J; Gorn-Hondermann I; Yarom N; Daneshmand M; Hanson JE; Addison CL; Asmis TR; Jonker DJ; Maroun J; Lorimer IA; Goss GD; Dimitroulakos J
Clin Exp Metastasis; 2012 Feb; 29(2):123-32. PubMed ID: 22120473
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
[TBL] [Abstract][Full Text] [Related]
14. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B
Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639
[TBL] [Abstract][Full Text] [Related]
15. High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer.
Yamazaki N; Koga Y; Taniguchi H; Kojima M; Kanemitsu Y; Saito N; Matsumura Y
Oncotarget; 2017 Jan; 8(4):6970-6983. PubMed ID: 28036302
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review.
Liu J; Ke F; Chen T; Zhou Q; Weng L; Tan J; Shen W; Li L; Zhou J; Xu C; Cheng H; Zhou J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):809-820. PubMed ID: 32146564
[TBL] [Abstract][Full Text] [Related]
17. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profiles in human colorectal cancers with liver metastases.
Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal monitoring reveals dynamic changes in circulating tumor cells (CTCs) and CTC-associated miRNAs in response to chemotherapy in metastatic colorectal cancer patients.
Tan K; Leong SM; Kee Z; Caramat PV; Teo J; Blanco MVM; Koay ESC; Cheong WK; Soh TI; Yong WP; Pang A
Cancer Lett; 2018 Jun; 423():1-8. PubMed ID: 29518480
[TBL] [Abstract][Full Text] [Related]
20. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]